Goldman Sachs initiates coverage on Hologic (NASDAQ: HOLX) with a Buy rating and $25 price target, suggesting 21% upside.
This article: 95 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE